LGALS3
Reaktivität: Human
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN979281
Kurzübersicht für Galectin 3 (LGALS3) Peptid (ABIN979281)
Target
Galectin 3 (LGALS3)
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-LGALS3 antibody (Catalog #: ARP54688_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
LGALS3
Reaktivität: Human, Maus
Wirt: Synthetic
BP, BI
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
Galectin 3 (LGALS3)
Substanzklasse
Chemical
Hintergrund
LGALS3 is a galactose-specific lectin which binds IgE. IT may mediate with the alpha-3, beta-1 integrin the stimulation by CSPG4 of endothelial cells migration. Together with DMBT1, it is required for terminal differentiation of columnar epithelial cells during early embryogenesis.
Alias Symbols: CBP35, GAL3, GALBP, GALIG, LGALS2, MAC2, L31
Protein Interaction Partner: CSNK1A1,CSNK2A1,CSNK2A2,CUBN,CYHR1,ELN,FCGR2A,GEMIN4,LGALS3BP,LIM2,MMP2,MYOC,SUFU,C1GALT1C1,ELN,FCGR2A,GEMIN4,LGALS1,LGALS3BP